Clinical Trials List
Protocol Number250-202
Completed
2018-04-20 - 2023-02-28
Phase II
Terminated1
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 林翔宇 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
33 participants
